Technology company Danaher Corporation (NYSE: DHR) Tuesday announced financial results for the third quarter of 2023, reporting lower sales and net profit. Third-quarter
DHR Earnings: Danaher Corporation Q3 2023 sales and profit decline
Categories
Healthcare
General Electric Company (GE) Q3 2023 Earnings Call Transcript
General Electric Company (NYSE: GE) Q3 2023 Earnings Call dated Oct. 24, 2023 Corporate Participants: Steve Winoker -- Vice President, Investor Relations
JNJ Earnings: All you need to know about Johnson & Johnson’s Q3 2023 earnings results
Johnson & Johnson (NYSE: JNJ) reported third quarter 2023 earnings results today. Reported sales increased 6.8% year-over-year to $21.3 billion. Operational sales
Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q3 2023 Earnings Call dated Oct. 17, 2023 Corporate Participants: Jessica Moore -- Vice President - Investor
Infographic: AngioDynamics reports adjusted loss for Q1 2024; sales down 4%
AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the first quarter of 2024 when its
Cardinal Health Inc Q4 2023 Earnings Conference Call Insights
Key highlights from Cardinal Health Inc (CAH) Q4 2023 Earnings Concall Management Update: [00:02:00] CAH delivered record financial performance, including its highest
Agilent Technologies Q3 2023 Earnings Call: Listen Live and Get the Real-Time Transcript
Medical device company Agilent Technologies, Inc. (NYSE: A) will be reporting financial results today evening, even as the earnings season reaches its
Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2023 results
Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted profit. Revenues
Earnings Summary: All you need to know about DexCom’s Q2 report
Healthcare company DexCom, Inc. (NASDAQ: DXCM) reported a double-digit increase in second-quarter earnings and also provided full-year guidance. Second-quarter revenue grew 25%
Johnson & Johnson (JNJ) Q2 2023 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported second quarter 2023 earnings results today. Reported sales increased 6.3% year-over-year to $25.5 billion. GAAP net
Novartis AG (NVS) Q2 2023 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q2 2023 earnings call dated Jul. 18, 2023 Corporate Participants: Samir Shah -- Global Head, Investor Relations Vasant (Vas) Narasimhan -- Chief
UnitedHealth Group Incorporated (UNH) Q2 2023 Earnings Call Transcript
UnitedHealth Group Incorporated (NYSE: UNH) Q2 2023 earnings call dated Jul. 14, 2023 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk McMahon -- Chief Operating
Organigram Holdings Inc (OGI) Q3 2023 Earnings Call Transcript
Organigram Holdings Inc (NASDAQ: OGI) Q3 2023 earnings call dated Jul. 14, 2023 Corporate Participants: Max Schwartz -- Director of Investor Relations Beena Goldenberg -- Chief
Angiodynamics Inc (ANGO) Q4 2023 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2023 earnings call dated Jul. 12, 2023 Corporate Participants: Jim Clemmer -- Chief Executive Officer Steve Trowbridge -- Chief Financial Officer
Walgreens Boots Alliance, Inc. (WBA) Q3 2023 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q3 2023 earnings call dated Jun. 27, 2023 Corporate Participants: Tiffany Kanaga -- Vice President of Global Investor
Avid Bioservices Inc. (CDMO) Q4 2023 Earnings Call Transcript
Avid Bioservices Inc. (NASDAQ: CDMO) Q4 2023 earnings call dated Jun. 21, 2023 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President and Chief
Patterson Companies, Inc. (PDCO) Q4 2023 Earnings Call Transcript
Patterson Companies, Inc. (NASDAQ: PDCO) Q4 2023 earnings call dated Jun. 21, 2023 Corporate Participants: John M. Wright -- Vice President of Investor Relations
CRESCO LABS INC-SUBORDINATE (CL) Q1 2023 Earnings Call Transcript
CRESCO LABS INC-SUBORDINATE (PNK : CL) Q1 2023 Earnings Call dated May. 24, 2023. Corporate Participants: Megan Kulick -- Senior Vice President,
Cara Therapeutics Inc (CARA) Q1 2023 Earnings Call Transcript
Cara Therapeutics Inc (NASDAQ: CARA) Q1 2023 earnings call dated May. 15, 2023 Corporate Participants: Matthew Murphy -- Manager of Investor Relations Christopher Posner -- Chief
Perrigo Co PLC (PRGO) Q1 2023 Earnings Call Transcript
Perrigo Co PLC (NYSE: PRGO) Q1 2023 Earnings Call dated May. 09, 2023. Corporate Participants: Bradley Joseph -- Vice President of Investor
A snapshot of McKesson Corporation’s Q4 2023 earnings
Healthcare service provider McKesson Corporation (NYSE: MCK) announced financial results for the fourth quarter of 2023, reporting a 4% increase in revenues.